Hillhouse Capital Advisors »

Contineum Therapeutics shares owned by Hillhouse Capital Advisors

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Hillhouse Capital Advisors from 13F filings

Historical chart of Hillhouse Capital Advisors investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Hillhouse Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Hillhouse Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $13M 669k 19.14
2024-06-30 $12M 669k 17.61

More positions owned by Hillhouse Capital Advisors

Beigene Sponsored Adr (BGNE)
Alibaba Group Hldg Sponsored Ads (BABA)
Pdd Holdings Sponsored Ads (PDD)
Legend Biotech Corp Sponsored Ads (LEGN)
Vipshop Hldgs Sponsored Ads A (VIPS)
Netease Sponsored Ads (NTES)
Ke Hldgs Sponsored Ads (BEKE)
Trip Com Group Ads (TCOM)
Arrivent Biopharma (AVBP)
Futu Hldgs Spon Ads Cl A (FUTU)
Zto Express Cayman Sponsored Ads A (ZTO)
Jd.com Spon Adr Cl A (JD)
Enfusion Cl A (ENFN)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Cytek Biosciences (CTKB)

View all positions for Hillhouse Capital Advisors

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Johnson & Johnson
Perceptive Advisors
Franklin Resources
Versant Venture Management
Hillhouse Capital Advisors
Samsara BioCapital
Vanguard Group
Altium Capital Management
BlackRock
BlackRock
Baker Bros. Advisors
Casdin Capital
Squarepoint Ops
Geode Capital Management

View all funds holding Contineum Therapeutics